David J Wyler

Title: David J Wyler: Innovator in Fibrosis Detection

Introduction

David J Wyler is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of medical science, particularly in the early detection of fibrosis. His innovative approach has the potential to improve the diagnosis and treatment of chronic inflammatory diseases.

Latest Patents

Wyler holds a patent for a method involving Fibroblast stimulating growth factor 1 (FsF-1) and the early detection of fibrosis. This method identifies individuals with a propensity for pathological fibrosis by providing a sample from an individual with a chronic inflammatory disease. The sample is then contacted with an antibody specific for fibroblast stimulating factor-1 (FsF-1) under conditions that allow for immunocomplex formation. An increase in the relative level of the immunocomplex indicates a propensity for pathological fibrosis. Additionally, his patent discloses FsF-1 polypeptides, antibodies specific for FsF-1, and DNA sequences encoding FsF-1 polypeptides.

Career Highlights

Wyler is associated with New England Medical Center Hospitals, Inc., where he continues to advance his research and innovations. His work is crucial in the medical field, particularly in understanding and detecting fibrosis.

Collaborations

Wyler has collaborated with notable colleagues, including Xiaoping Zhang and Sadhana Prakash. Their combined expertise contributes to the advancement of medical research and innovation.

Conclusion

David J Wyler's contributions to the detection of fibrosis through his patented methods highlight his role as an important inventor in the medical field. His work not only enhances our understanding of chronic inflammatory diseases but also paves the way for improved diagnostic techniques.